Avotaciclib

• Description:

  Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  281.27

• Molecular Formula:

  C13H11N7O

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK

• CAS Number:

  1983983-41-0